专利检索 ap:("Betta Pharmaceuticals Co., Ltd") AND inv:"XU, Wei" 第 1 页

1.

发明公开
APPLICATION OF COMPOUND IN PREPARATION OF DRUG FOR TREATING MYELOFIBROSIS AND RELATED SYMPTOMS/SIGNS THEREOF, AND USE OF COMPOUND 审中-实审

公开(公告)号：EP4360634A1

公开(公告)日：2024-05-01

申请号：EP22827568.1

申请日：2022-06-21

申请人： Betta Pharmaceuticals Co., Ltd

发明人： GUO, Jing , YAN, Dan , WANG, Yu , XU, Tong , LI, Kao , XU, Wei , LAN, Hong , DING, Lieming , WANG, Jiabing

IPC分类号： A61K31/4985 , A61P35/00

CPC分类号： A61K31/4985 , A61P35/00

摘要： The present invention provides an application of a compound in the preparation of drug for treating myelofibrosis and the related symptoms/signs thereof, and a use of the compound. The compound is selected form one or more of a compound having a structure as shown in formula I, and a pharmaceutically-acceptable salt, prodrug, solvate and hydrate thereof.